Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $786.57 billion, total revenue of $167.58 billion and a weighted average PE ratio of 50.12.
Market Cap
786.57B
Revenue
167.58B
Profits
15.69B
PE Ratio
50.12
Profit Margin
9.36%
Dividend Yield
0.20%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 218.48B | -1.80% | 726,680 | 44.56B |
| 2 | DHR | Danaher Corporation | 155.82B | 0.37% | 1,116,754 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 54.05B | 0.02% | 68,350 | 4.17B |
| 4 | IQV | IQVIA Holdings Inc. | 39.12B | -2.50% | 191,928 | 15.90B |
| 5 | A | Agilent Technologies, Inc. | 37.78B | - | 104,835 | 6.95B |
| 6 | NTRA | Natera, Inc. | 31.73B | -0.90% | 108,410 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.41B | -0.14% | 17,601 | 3.94B |
| 8 | LH | Labcorp Holdings Inc. | 22.34B | -0.13% | 68,112 | 13.77B |
| 9 | ILMN | Illumina, Inc. | 22.30B | -2.49% | 202,554 | 4.29B |
| 10 | WAT | Waters Corporation | 22.10B | -1.04% | 54,099 | 3.11B |
| 11 | DGX | Quest Diagnostics Incorporated | 20.49B | 1.03% | 91,164 | 10.85B |
| 12 | EXAS | Exact Sciences Corporation | 19.45B | 0.17% | 196,141 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.52B | -1.12% | 13,044 | 2.36B |
| 14 | GH | Guardant Health, Inc. | 14.08B | -1.11% | 244,422 | 902.57M |
| 15 | ICLR | ICON Public Limited Company | 13.65B | -3.86% | 308,738 | 8.10B |
| 16 | RVTY | Revvity, Inc. | 12.13B | -1.40% | 123,292 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 10.88B | -1.64% | 309,135 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 10.31B | -1.00% | 41,770 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 5.40B | -1.17% | 52,769 | 1.97B |
| 20 | SHC | Sotera Health Company | 5.10B | -1.97% | 93,878 | 1.15B |
| 21 | GRAL | GRAIL, Inc. | 3.92B | -0.49% | 115,571 | 141.83M |
| 22 | BLLN | BillionToOne, Inc. | 3.77B | 1.45% | 58,311 | 254.14M |
| 23 | VCYT | Veracyte, Inc. | 3.00B | -2.17% | 52,904 | 495.14M |
| 24 | WGS | GeneDx Holdings Corp. | 2.77B | -2.33% | 71,011 | 402.19M |
| 25 | TWST | Twist Bioscience Corporation | 2.47B | -2.98% | 178,502 | 376.57M |
| 26 | NEOG | Neogen Corporation | 2.22B | -0.20% | 508,418 | 880.32M |
| 27 | NEO | NeoGenomics, Inc. | 1.56B | -2.74% | 145,042 | 709.16M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.12B | -1.94% | 45,212 | 343.53M |
| 29 | CDNA | CareDx, Inc. | 1.06B | -0.48% | 80,039 | 358.00M |
| 30 | OPK | OPKO Health, Inc. | 955.79M | -1.97% | 1,311,924 | 642.07M |
| 31 | PSNL | Personalis, Inc. | 826.77M | -6.62% | 146,776 | 69.10M |
| 32 | FLGT | Fulgent Genetics, Inc. | 802.49M | -1.07% | 12,021 | 315.55M |
| 33 | MYGN | Myriad Genetics, Inc. | 511.74M | -0.90% | 56,498 | 825.30M |
| 34 | BNR | Burning Rock Biotech Limited | 365.96M | 1.34% | 3,324 | 75.75M |
| 35 | PRE | Prenetics Global Limited | 335.90M | -2.54% | 101,603 | 77.08M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 186.18M | -1.89% | 3,020 | 4.40M |
| 37 | MDXH | MDxHealth SA | 175.72M | -0.28% | 25,456 | 103.07M |
| 38 | FONR | FONAR Corporation | 121.98M | -0.16% | 1,318 | 105.43M |
| 39 | XGN | Exagen Inc. | 82.27M | -8.10% | 123,662 | 63.60M |
| 40 | BDSX | Biodesix, Inc. | 72.48M | -5.69% | 50,109 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 42.07M | -1.03% | 463 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 17.18M | -2.87% | 30,730 | 513.02M |
| 43 | MBAI | Check-Cap Ltd. | 11.32M | -2.12% | 126,148 | - |
| 44 | MYNZ | Mainz Biomed N.V. | 10.60M | -5.65% | 72,020 | 659.94K |
| 45 | ADVB | Advanced Biomed Inc. | 6.34M | 5.73% | 4,992 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 5.30M | 0.85% | 3,985 | 6.78M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 4.50M | -3.50% | 2,113 | - |
| 48 | ISPC | iSpecimen Inc. | 3.37M | 4.80% | 16,438 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 1.56M | -5.22% | 37,974 | 29.52M |